In the absence of AVJ16 treatment, LKR-M-Fl cells show a two to three-fold increase in tumor size compared to LKR-M-GFP, indicating that exogenous IGF2BP1 promotes tumor progression in these xenografts (compare Fig. 7B, C with Supplementary Fig. 7C). This evidence concerns the gene IGF2BP1 and neoplasm.